Bristol Myers Squibb (CELG-RI) Shares Outstanding (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has reported Shares Outstanding (Entity) for 18 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) changed 0.36% year-over-year to $2.0 billion; the TTM figure through Jun 2026 stood at $2.0 billion (changed 0.36% YoY), while the FY2025 annual figure was $2.0 billion, changed 0.35% from the prior year.
• Shares Outstanding (Entity) steadied at $2.0 billion in Q2 2026 per CELG-RI's latest filing, from $2.0 billion in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $2.1 billion in Q2 2022 and bottomed at $2.0 billion in Q4 2024.
• Historically, Shares Outstanding (Entity) has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2025.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) declined 4.65% — and 2025, when it gained 0.4%.
• Bristol Myers Squibb's Shares Outstanding (Entity) stood at $2.1 billion in 2022, then retreated by 2.86% to $2.1 billion in 2023, then retreated by 2.03% to $2.0 billion in 2024, then advanced by 0.35% to $2.0 billion in 2025, then gained by 0.43% to $2.0 billion in 2026.
• Business Quant data shows CELG-RI's Shares Outstanding (Entity) at $2.0 billion in Q2 2026, $2.0 billion in Q1 2026, and $2.0 billion in Q4 2025.